NYC Health + Hospitals/Lincoln Awarded Designation as Center of Excellence in Lung Cancer Screening
GO2 for Lung Cancer recognizes Lincoln Hospital for its commitment to highest standards in lung cancer early detection through low dose CT screenings
Apr 28, 2026
NYC Health + Hospitals/Lincoln announced today that the hospital has been named a Center of Excellence by GO2 for Lung Cancer (GO2) – a nationally recognized organization that supports lung cancer care and research. This designation recognizes Lincoln Hospital for its ongoing commitment to providing the South Bronx community with patient-centered, evidence-based lung cancer screenings.
“This national recognition is a testament to the dedication, collaboration, and compassion of our NYC Health + Hospitals/Lincoln Cancer Center team,” said Cristina Contreras, LMSW, MPA, FABC, DHL, NYC Health + Hospitals/Lincoln Chief Executive Officer. “Their continued commitment to excellence and patient-centered care ensures that our community receives the very best in prevention and treatment. This designation highlights our unwavering commitment to the early detection of and relentless pursuit of a world without lung cancer and places us at the forefront of the battle, offering hope to those in need.”
“Becoming a Lung Cancer Screening Center of Excellence acknowledges the amazing and life-saving work of our lung cancer screening team under the leadership of Dr. Alan Kantor,” said Lewis Marshall, MD, Chief Medical Officer, NYC Health + Hospitals/Lincoln. “As our Chair of Radiology Services, Dr. Kantor’s efforts in building a multidisciplinary, patient-centered approach to early detection, treatment, and follow-up care have been integral to earning this prestigious recognition. Low dose CT screening is currently the only proven method to detect lung cancer at the earliest, most treatable stage. We are thrilled to be part of this elite group, setting an example for responsible screening practices across the country.”
“We are proud to have NYC Health + Hospitals/Lincoln join the community of GO2 for Lung Cancer Centers of Excellence that is national in scope and local in impact,” said GO2 Chief Healthcare Delivery Officer, Joelle Fathi. “Across the U.S., the majority of people at risk for or living with lung cancer are served by a local community hospital near their home. Through the GO2 COE network of community hospitals, clinics, and academic and VA medical centers, we are fostering and supporting essential knowledge sharing and collaboration that brings national and global advancements in early detection, treatment and care close to home.”
According to GO2, an estimated 237,000 Americans are diagnosed with lung cancer annually, with most cancers found at an advanced stage of the disease. As a result, lung cancer has long been the leading cause of cancer deaths in the U.S. By screening individuals at high risk for lung cancer using low dose computed tomography (LDCT), this disease can now be found early, when it is most treatable and even curable.
As a designated GO2 Center of Excellence in lung cancer screening, NYC Health + Hospital/Lincoln is committed to the principles of patient-centered communication and decision making across the entire care pathway. That means that the hospital implements screening in accordance with current evidence and clinical guidelines developed by professional bodies such as the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN), and coordinate patient follow-up, diagnostics, and transition to treatment through a multidisciplinary clinical process. Lincoln Hospital offers lung cancer screening for people who are between the ages of 50 and 80, have a history of heavy smoking, are currently using tobacco or stopped within the past 15 years, and have no signs or symptoms of underlying lung cancer.
If you would like to receive more information about the Lung Cancer Screening Program or make an appointment, please call 718-579-5218.
###
MEDIA CONTACT: Natasha Burke, NYC Health + Hospitals/Lincoln, 929-837-9166
#090-26
About NYC Health + Hospitals/Lincoln
NYC Health + Hospitals/Lincoln, located in the South Bronx, is a 362-bed, Acute Care Level 1 Trauma Center and sees more than 168,000 emergency room visits and more than 600,000 outpatient visits annually. Clinical centers of excellence include: Emergency Medicine and Trauma Care; Breast Imaging; Designated Stroke Center, Diabetes Center and HIV/AIDS Center. Lincoln Hospital was the first Baby-Friendly designated hospital in the Bronx, providing clinical services and consultations for over 1,500 deliveries per year. The hospital emphasizes primary care and specialty medicine, using the latest advances in medical science. Lincoln is part of NYC Health + Hospitals, the largest public health care system in the nation. For more information visit www.nychealthandhospitals.org/lincoln or follow us on Instagram at www.Instagram.com/LincolnHospBX and Facebook at www.facebook.com/LincolnHosp.
About NYC Health + Hospitals
NYC Health + Hospitals is the largest municipal health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city’s five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system’s trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlusHealth plan—all supported by 11 essential hospitals. Its diverse workforce of more than 46,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit www.nychealthandhospitals.org and stay connected on Facebook, Twitter, Instagram and LinkedIn.
About GO2 for Lung Cancer
GO2 for Lung Cancer relentlessly confronts lung cancer on every front, every day, for everyone. Founded by patients and survivors, GO2 is dedicated to increasing survival for those at risk, diagnosed and living with lung cancer. For more information visit go2.org, like us on Facebook/Instagram (@GO2forLungCancer) and follow us on Twitter (@go2forlungcancr) and LinkedIn (@go2forlungcancer).